Edwards Lifesciences (EW) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free EW Stock Alerts $89.14 -0.97 (-1.08%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Edwards Lifesciences Short Interest DataCurrent Short Volume9,630,000 sharesPrevious Short Volume7,380,000 sharesChange Vs. Previous Month+30.49%Dollar Volume Sold Short$815.47 millionShort Interest Ratio / Days to Cover2.7Last Record DateApril 30, 2024Outstanding Shares602,600,000 sharesFloat Size593,080,000 sharesShort Percent of Float1.62%Today's Trading Volume2,063,096 sharesAverage Trading Volume3,624,532 sharesToday's Volume Vs. Average57% Short Selling Edwards Lifesciences ? Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEW Short Interest Over TimeEW Days to Cover Over TimeEW Percentage of Float Shorted Over Time Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. Edwards Lifesciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,630,000 shares $815.47 million +30.5%1.6%2.7 $84.68 4/15/20247,380,000 shares $658.30 million -28.9%1.3%1.9 $89.20 3/31/202410,380,000 shares $991.91 million -0.7%1.8%2.6 $95.56 3/15/202410,450,000 shares $964.64 million +23.8%1.8%2.7 $92.31 2/29/20248,440,000 shares $716.30 million -16.4%1.4%1.9 $84.87 2/15/202410,090,000 shares $868.35 million +1.3%1.7%2.3 $86.06 Get the Latest News and Ratings for EW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20249,960,000 shares $781.56 million -8.4%1.7%2.2 $78.47 1/15/202410,870,000 shares $804.71 million +2.0%1.8%2.4 $74.03 12/31/202310,660,000 shares $812.83 million -21.3%1.8%2.3 $76.25 12/15/202313,540,000 shares $1.04 billion +34.7%2.3%2.8 $76.90 11/30/202310,050,000 shares $680.49 million -6.5%1.7%2.3 $67.71 11/15/202310,750,000 shares $720.36 million -6.3%1.8%2.6 $67.01 10/31/202311,470,000 shares $730.87 million -1.1%1.9%2.9 $63.72 10/15/202311,600,000 shares $821.05 million -13.4%1.9%3.1 $70.78 9/30/202313,400,000 shares $928.35 million +5.5%2.2%3.8 $69.28 9/15/202312,700,000 shares $929.64 million +18.1%2.1%4 $73.20 8/31/202310,750,000 shares $822.05 million +13.0%1.8%3.4 $76.47 8/15/20239,510,000 shares $759.47 million +0.4%1.6%3 $79.86 7/31/20239,470,000 shares $777.20 million -2.9%1.6%3.3 $82.07 7/15/20239,750,000 shares $910.46 million -0.9%1.6%3.7 $93.38 6/30/20239,840,000 shares $928.21 million -4.4%1.6%3.7 $94.33 6/15/202310,290,000 shares $939.37 million -7.4%1.7%3.8 $91.29 5/31/202311,110,000 shares $935.91 million +12.9%1.9%3.9 $84.24 5/15/20239,840,000 shares $874.97 million +7.2%1.6%3.2 $88.92 4/30/20239,180,000 shares $807.66 million -27.3%1.5%2.8 $87.98 4/15/202312,620,000 shares $1.06 billion -10.1%2.1%3.6 $84.36 3/31/202314,040,000 shares $1.16 billion -17.1%2.3%4.1 $82.73 3/15/202316,940,000 shares $1.35 billion +32.7%2.8%4.7 $79.48 2/28/202312,770,000 shares $1.03 billion +6.8%2.1%3.2 $80.44 2/15/202311,960,000 shares $931.92 million -12.4%2.0%3 $77.92 1/31/202313,650,000 shares $1.05 billion -2.0%2.2%3 $76.70 1/15/202313,930,000 shares $1.09 billion -9.2%2.3%2.7 $78.31 12/30/202215,340,000 shares $1.14 billion +9.9%2.5%3 $74.61 12/15/202213,960,000 shares $1.03 billion +27.0%2.3%2.8 $73.55 11/30/202210,990,000 shares $848.98 million +4.0%1.8%2.3 $77.25 11/15/202210,570,000 shares $802.90 million +30.3%1.7%2.5 $75.96 10/31/20228,110,000 shares $587.41 million +8.9%1.3%2.2 $72.43 10/15/20227,450,000 shares $614.03 million -1.7%1.2%2.7 $82.42 9/30/20227,580,000 shares $626.34 million +15.9%1.2%3 $82.63 9/15/20226,540,000 shares $620.52 million +77.7%1.1%2.5 $94.88A letter is coming from the "Bureau of the Fiscal Service". (Ad)Is your bank next? A powerful new trend is spreading like wildfire inside the US financial system. At least 41 banks are already involved. But the Federal Reserve predicts that number will grow fast.See if your bank is involved right here. EW Short Interest - Frequently Asked Questions What is Edwards Lifesciences' current short interest? Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 9,630,000 shares of EW short. 1.62% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest. What is a good short interest ratio for Edwards Lifesciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 3.0. Learn More on Edwards Lifesciences's short interest ratio. Which institutional investors are shorting Edwards Lifesciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edwards Lifesciences: Walleye Trading LLC, Jane Street Group LLC, Paloma Partners Management Co, PEAK6 Investments LLC, Twin Tree Management LP, BNP Paribas Financial Markets, SpiderRock Advisors LLC, Caas Capital Management LP, Wealth Enhancement Advisory Services LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Edwards Lifesciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.62% of Edwards Lifesciences' floating shares are currently sold short. Is Edwards Lifesciences' short interest increasing or decreasing? Edwards Lifesciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 9,630,000 shares, an increase of 30.5% from the previous total of 7,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edwards Lifesciences' float size? Edwards Lifesciences currently has issued a total of 602,600,000 shares. Some of Edwards Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edwards Lifesciences currently has a public float of 593,080,000 shares. How does Edwards Lifesciences' short interest compare to its competitors? 1.62% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Edwards Lifesciences: STERIS plc (2.41%), Intuitive Surgical, Inc. (0.98%), Zimmer Biomet Holdings, Inc. (2.08%), Align Technology, Inc. (1.83%), DexCom, Inc. (2.79%), Moderna, Inc. (6.26%), Cencora, Inc. (4.88%), Alcon Inc. (0.67%), IDEXX Laboratories, Inc. (2.07%), Takeda Pharmaceutical Company Limited (0.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Edwards Lifesciences stock? Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading down $0.97 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edwards Lifesciences? A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further. How often is Edwards Lifesciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: STE Short Squeeze ISRG Short Squeeze ZBH Short Squeeze ALGN Short Squeeze DXCM Short Squeeze MRNA Short Squeeze COR Short Squeeze ALC Short Squeeze IDXX Short Squeeze TAK Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EW) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits